During admission | Ref | |
---|---|---|
AST U/L | 18 | 7–55 |
ALT U/L | 13 | 8–48 |
ALK-Ph U/L | 636 | 40–129 |
Bili T. mg/dL | 1.1 | 0.1–1.2 |
Bili D. mg/dl | 0.5 | <0.3 |
CPK U/L | 81 | 39–308 |
LDH U/L | 711 | 140–280 |
Alb g/dL | 3.15 | 3.4–5.4 |
Amylase U/L | 34 | 23–85 |
Lipase U/L | 36 | 0–160 |
PT sec | 13 | 10–13 |
PTT sec | 27 | 25–36 |
INR | 1 | 0.9–1.15 |
CL mmol/L | 97.9 | 95–110 |
Anti-DNA IU/mL | 1.2 | < 30.0 |
C3 g/L | 152 | 0.9–1.8 |
C4 g/L | 57 | |
CH50 mg/dl | 89.4 | low:0–100 nl:101–300 hi > 301 |
ANA u/ml | 0.7 | neg. < 0.8 equ:0.8–1.2 pos. < 1.2 |
ANCA | 0.6 | neg .< 12 equ:12–18 pos. < 18 |
P ANCA | 0.1 | |
Urine24h,cr mg/24 h | 575 | 800–2000 |
Urine24h,pro.mg/24 h | 497 | |
Urine24h,vol. ml | 1150 | 600–2500 |
Urine24h,k meq/24 h | 49.5 | 30–120 |